Bioleap (Drug Discovery) Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Bioleap (Drug Discovery) General Information
Description
Developer of advanced multi-modal therapies designed to cure complex diseases. The company's platform integrates physics, biology, and artificial intelligence to model and predict therapeutic responses, enabling researchers in the immuno-oncology market to accelerate the discovery and development of new biologics.
Contact Information
Website
www.bioleap.aiCorporate Office
- Salisbury House, Station Road
- Cambridge CB1 2LA
- England, United Kingdom
Corporate Office
- Salisbury House, Station Road
- Cambridge CB1 2LA
- England, United Kingdom
Bioleap (Drug Discovery) Timeline
Bioleap (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | Completed | Clinical Trials - Phase 3 | ||||
| 3. Seed Round | 26-Jul-2024 | Completed | Clinical Trials - Phase 3 | |||
| 2. Accelerator/Incubator | 01-Jan-2023 | $394K | Completed | Startup | ||
| 1. Seed Round | 05-Apr-2022 | $394K | $394K | Completed | Startup |
Bioleap (Drug Discovery) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Bioleap (Drug Discovery) Signals
Bioleap (Drug Discovery) Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas SGR | Asset Manager | Minority | ||
| P4 Precision | Accelerator/Incubator | |||
| SFC Capital | Venture Capital | Minority | ||
| West Midlands Health Tech Innovation Accelerator | Accelerator/Incubator |
Bioleap (Drug Discovery) FAQs
-
When was Bioleap (Drug Discovery) founded?
Bioleap (Drug Discovery) was founded in 2022.
-
Where is Bioleap (Drug Discovery) headquartered?
Bioleap (Drug Discovery) is headquartered in Cambridge, United Kingdom.
-
What is the size of Bioleap (Drug Discovery)?
Bioleap (Drug Discovery) has 6 total employees.
-
What industry is Bioleap (Drug Discovery) in?
Bioleap (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Bioleap (Drug Discovery) a private or public company?
Bioleap (Drug Discovery) is a Private company.
-
What is Bioleap (Drug Discovery)’s current revenue?
The current revenue for Bioleap (Drug Discovery) is .
-
How much funding has Bioleap (Drug Discovery) raised over time?
Bioleap (Drug Discovery) has raised $394K.
-
Who are Bioleap (Drug Discovery)’s investors?
Atlas SGR, P4 Precision, SFC Capital, and West Midlands Health Tech Innovation Accelerator have invested in Bioleap (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process